General news

New venture to produce rabies virus neutralising antibody secures a big win for the CSIR A proposed new start-up venture, GreenPharm™, that intends producing cost-effective anti-rabies prophylaxis in plants, specifically tobacco leaves, was named the inaugural winner of the SA Bio Business Plan Competition, walking away with prize money of R100 000 and an investment indication of up to R15 million.

Siamon Gordon appointed as CSIR fellow South African expatriate and Glaxo Wellcome Professor of Pathology at the University of Oxford in the UK, Siamon Gordon, has been appointed as a CSIR Fellow. The appointment came shortly before Gordon gave a lecture on macrophages and their role in HIV and TB at the CSIR President's Lecture series.